The Centers for Disease Control and Prevention is working to expand testing for monkeypox across the country.
Monkeypox is a rare virus associated with flu-like symptoms, swelling of the lymph nodes, and a rash with fluid-filled bumps. Unlike COVID-19, monkeypox is not new; it was first discovered in 1958.
SEE ALSO: First monkeypox case confirmed in North Carolina
A vaccine against the virus already exists. Also, the virus is not as easily transmitted as COVID-19.
These reasons are just some of the reasons health experts are not as concerned about monkeypox becoming a global problem as COVID-19 has been in recent years.
Still, the US government is working to expand testing capabilities and access to vaccines and treatments.
What is monkeypox and should you be concerned? Questions and Answers with Dr. David Wohl
Part of that initiative includes moving the monkeypox PCR test to national labs like Labcorp so people can be tested quickly when needed.
“Labcorp appreciates the opportunity to support the CDC in its efforts to keep the public safe and manage the monkeypox outbreak,” said Dr. Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics. “We will initially conduct all monkeypox testing at our main laboratory in North Carolina and have the capacity to expand to other locations across the country as needed.”
Lapcorp anticipates eventually being able to process up to 10,000 tests per week, doubling the capacity currently available through the CDC.
LGBTQ advocates talk about ‘red flags’ related to monkeypox information
Copyright © 2022 WTVD-TV. All rights reserved.
https://abc13.com/monkeypox-test-labcorp-nc-what-is/12023448/ Labcorp: The North Carolina company will offer a monkeypox test, doubling US testing capacity